-+ 0.00%
-+ 0.00%
-+ 0.00%
12 Health Care Stocks Moving In Wednesday's After-Market Session
Share
Listen to the news

Gainers

  • Curis (NASDAQ:CRIS) stock rose 9.0% to $0.46 during Wednesday's after-market session. The company's market cap stands at $20.3 million.
  • Humacyte (NASDAQ:HUMA) shares moved upwards by 5.45% to $0.71. The market value of their outstanding shares is at $210.4 million.
  • Medicus Pharma (NASDAQ:MDCX) shares increased by 5.19% to $0.42. The company's market cap stands at $25.2 million.
  • Chemomab Therapeutics (NASDAQ:CMMB) shares increased by 4.06% to $1.79. The company's market cap stands at $11.6 million.
  • OSR Health (NASDAQ:OSRH) shares moved upwards by 4.03% to $0.32. The market value of their outstanding shares is at $11.1 million.
  • Solid Biosciences (NASDAQ:SLDB) shares moved upwards by 3.92% to $10.6. The market value of their outstanding shares is at $983.5 million.

Losers

  • Galmed Pharmaceuticals (NASDAQ:GLMD) stock fell 14.4% to $0.55 during Wednesday's after-market session. The market value of their outstanding shares is at $4.2 million.
  • rYojbaba (NASDAQ:RYOJ) stock declined by 10.55% to $2.8. The market value of their outstanding shares is at $28.9 million.
  • Profusa (NASDAQ:PFSA) stock declined by 7.77% to $0.12.
  • Aethlon Medical (NASDAQ:AEMD) stock fell 7.33% to $0.7. The company's market cap stands at $1.9 million.
  • Universe Pharmaceuticals (NASDAQ:UPC) stock fell 7.2% to $5.16. The market value of their outstanding shares is at $3.9 million.
  • NewGenIvf Group (NASDAQ:NIVF) stock decreased by 7.13% to $0.51. The company's market cap stands at $5.3 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending